UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
_________________
Date of Report (Date of earliest event reported): July 5, 2012
InspireMD, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Delaware
|
|
|
|
26-2123838
|
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
4 Menorat Hamaor St.
Tel Aviv, Israel
|
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code: 972-3-691-7691
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01 Regulation FD Disclosure.
Attached hereto as Exhibit 99.1 is a PowerPoint presentation that InspireMD, Inc. will present at the JMP Securities Healthcare Conference in New York on Thursday, July 12, 2012.
The information furnished in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
On July 5, 2012, InspireMD, Inc. issued a press release announcing that it will present at the JMP Securities Healthcare Conference in New York on Thursday, July 12, 2012. A copy of this press release is attached hereto as Exhibit 99.2 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit Number
|
|
Description
|
|
99.1
|
|
Investor Presentation
|
|
99.2
|
|
Press Release dated July 5, 2012.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
INSPIREMD, INC.
|
|
| |
|
|
|
|
|
By:
|
|
|
| |
|
Name: Craig Shore
|
|
| |
|
Title: Chief Financial Officer
|
|
| |
|
|
|
EXHIBIT INDEX
|
Exhibit Number
|
|
Description
|
|
99.1
|
|
Investor Presentation
|
|
99.2
|
|
Press Release dated July 5, 2012.
|